Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia Coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model
Toxins - Switzerland
doi 10.3390/toxins9020049
Full Text
Open PDFAbstract
Available in full text
Date
January 26, 2017
Authors
Publisher
MDPI AG